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Abstract
Background: Small supernumerary marker chromosomes (sSMC) are extra structurally abnormal chromosomes that
cannot be unambiguously identified with conventional chromosome banding techniques. These marker
chromosomes may cause an abnormal phenotype or be harmless depending on different factors such as genetic
content, chromosomal origin and level of mosaicism. When a sSMC is found during prenatal diagnosis, the main
question is whether the sSMC contains euchromatin since in most cases this will lead to phenotypic abnormalities.
We present the use of Multiplex Ligation Dependent probe Amplification (MLPA) for rapid distinction between
non-euchromatic and euchromatic sSMC.
Results: 29 well-defined sSMC found during prenatal diagnosis were retrospectively investigated with MLPA with
the SALSA MLPA centromere kits P181 and P182 as well as with the SALSA MLPA telomere kits P036B and P070
(MRC Holland BV, Amsterdam, The Netherlands). All unique-sequence positive sSMC were correctly identified with
MLPA, whereas the unique-sequence negative sSMC had normal MLPA results.
Conclusions: Although different techniques exist for identification of sSMC, we show that MLPA is a valuable
adjunctive tool for rapidly distinguishing between unique-sequence positive and negative sSMC. In case of positive
MLPA results, genetic microarray analysis or, if not available, targeted FISH can be applied for further identification
and determination of the exact breakpoints, which is important for prediction of the fetal phenotype. In case of a
negative MLPA result, which means that the sSMC most probably does not contain genes, the parents can already
be reassured and parental karyotyping can be initiated to assess the heritability. In the mean time, FISH techniques
are needed for determination of the chromosomal origin.
Background
The finding of a sSMC presents a challenge in prenatal
diagnosis particularly for prediction of the clinical con-
sequences which will depend on its genetic content,
familial occurrence, level of mosaicism and chromoso-
mal origin [1-5] and parental origin of the sSMC related
sister chromosomes [6]. According to the review of
Liehr and Weise [7] sSMC are to be expected in 0.075%
of all analysed prenatal cases. In case of fetal ultrasound
abnormalities this frequency rises to 0.204%, which is
2.7x higher than in the general prenatal population.
Before the introduction of FISH for cytogenetics, iden-
tification studies involved the use of classical staining
techniques such as GTG, QFQ, Ag-NOR, CBG and DA-
DAPI [1]. Nowadays, different molecular cytogenetic
techniques have been developed for identification of
sSMC, such as FISH techniques like cenM- and sub-
cenM-FISH [8,9], multicolour banding (MCB)[10],
microdissection followed by reverse FISH [11,12], spec-
tral karyotyping (SKY) [13], M-FISH [14] and genomic
microarray analysis [15,16]. These techniques are expen-
sive and not available in all cytogenetic laboratories [17].* Correspondence: a.vanopstal@erasmusmc.nl
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In this paper we present the use of Multiplex Ligation
Dependent Probe Amplification (MLPA) (MRC Holland,
Amsterdam, The Netherlands) as an alternative
approach for identification of euchromatic sSMC. On
the basis of 29 well characterised sSMC we show that
MLPA can rapidly distinguish between unique sequence
positive and negative sSMC, which is the most impor-
tant task when finding a sSMC prenatally. However,
other molecular cytogenetic techniques will remain
necessary for determining the exact genetic content in
case of a positive sSMC, whereas FISH techniques will
still be indispensible for identification studies in case of
an unique sequence negative sSMC.
Methods
Samples
We retrospectively tested the value of MLPA for sSMC
identification on 29 well-defined sSMC found during
prenatal diagnosis in amniotic fluid (AF)(n = 26) and
chorionic villi (CV)(n = 3) (see table 1 and additional
file 1). For routine cytogenetics GTG-banding was used
in all cases according to standard techniques. Mostly,
sSMC identification was done with FISH, sometimes
after additional staining with DA-DAPI [18] (see addi-
tional file 1). In 23/29 cases the sSMC was present in all
investigated cells. In 6/29 cases mosaicism was found in
cultured CV or AF cells with the level of mosaicism
varying between 30 and 89% (table 1).
FISH
Metaphase FISH was performed according to standard
techniques. The probes that were used for identification
were whole chromosome paints (wcp’s)(Kreatech Diagnos-
tics, Ankeveen, The Netherlands and Euro-Diagnostica AB,
Nijmegen, The Netherlands), centromere probes (Abbott
Molecular Inc., Des Plaines, USA; Resources for Molecular
Cytogenetics, Bari, Italy (http://www.biologia.uniba.it/rmc/)
and partially received from several investigators), subtelo-
mere-probes [19], locus-specific probes (SNRPN from
Cytocell Ltd, Cambridge, UK; LSI TEL AML1 from Abbott
Molecular Inc., Des Plaines, USA and others like 102D10
(CES-probe), Y41 and Y11H11 (15q11), r521 (rDNA-
probe) were kindly provided by several investigators) and
subcentromere-BAC clones that were selected from the
University of California Santa Cruz (UCSC) genome brow-
ser (http://genome.ucsc.edu) (see additional file 1).
FISH slides were analyzed using the Axioplan 2 Ima-
ging microscope (Zeiss), and images were collected
using Isis Software System (Metasystems).
Sample preparation for MLPA and SNP array
DNA was isolated from 4 ml of uncultured AF or from
cultured CV or AF cells. AF cells were cultured by the
Table 1 29 well-defined sSMC in AF or CV cell cultures
that were used in this study
Case sSMC Euchromatin (based on
GTG/FISH)1
% of cultured cells
with sSMC
1 der(3)(:p12.2-
>cen:)2
+ 100
2 min(4)(:p11-
>q11:)
- 100
3 psu idic(9)(q12) + 87,5
4 i(12)(p10) + 89
5 i(12)(p10) + 100
6 neo(12)
(pter->p12.3:)
+ 47
7 der(13)t(4;13)
(q31.3;q13)
+ 100
8 min(13 or 21) - 100
9 min(13 or 21) - 100
10 inv dup(14)
(q11.2)
- 100
11 der(14)t(14;16)
(q12;q21)
+ 100
12 inv dup(15)
(q12)
+ 100
13 neo(15)(qtel-
>q2?4:)3
+ 100
14 der(15)t(9;15)
(p12;q14)
+ 100
15 inv dup(15)
(q11)
- 100
16 inv dup(15)
(q11.2)
- 100
17 inv dup(15)
(q11.2)
- 100
18 min(16)(:p11.1-
>q11.1:)
- 30
19 min(17)(:p11.1-
>q11.1:)
- 45
20 r(20)
(q11.21q13.12)
+ 87
21 inv dup(22)
(q11.21)
+ 100
22 inv dup(22)
(q11.21)
+ 100
23 inv dup(22)
(q11.21)
+ 100
24 inv dup(22)
(q11.21)
+ 100
25 del(22)(q11.2) + 100
26 inv dup(22)
(q11.1)
- 100
27 inv dup(22)
(q11.1)
- 100
28 inv dup(22)
(q11.1)
- 100
29 inv dup(22)
(q11.1)
- 100
1 For identification details, see additional file 1[38]. 2 This case was previously
published by Srebniak et al. [39]. 3This case was published earlier by Van
Opstal et al. [40].
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in situ method and CV were cultured using trypsin-
EDTA and collagenase treatment as described previously
[20]. DNA-isolation from uncultured AF cells was done
with the Chemagic Magnetic Separation Module I (Che-
magen, Baesweiler, Germany). DNA isolation from cul-
tured cells was performed using the QIAamp DNA Mini
Kit from Qiagen (Hilden, Germany) or Puregene DNA
Purification Kit (Qiagen, Hilden, Germany) according to
the manufacturer’s instructions.
MLPA-reaction and data analysis
4 SALSA MLPA kits were used: two centromere kits,
P181 and P182, and two telomere-kits, P036B and P070
(http://www.mlpa.com/WebForms/WebFormMain.aspx).
Between 20 and 70 ng of DNA was used in a MLPA reac-
tion which was performed on a PCR thermocycler with
heated lid (Biometra Thermal Cycler, Westburg, The
Netherlands). MLPA reaction and data analysis were per-
formed as described earlier [21]. In order to enable the
detection of chromosomal mosaicism as was seen in 6/29
cases, we calculated own cut off values (median ± 2x SD)
for the different probes on the different chromosomes for
all four MLPA-kits on the basis of 95 (P181), 91 (P182),
104 (P036B) and 105 (P070) normal samples (see table 2).
SNP array, data analysis and interpretation
In two cases (cases 13 and 25) a SNP array (HumanCy-
toSNP-12, Illumina) was performed because of discre-
pancies between the results of GTG/FISH and MLPA.
200 ng of DNA isolated from cultured cells was used in
both cases. DNA amplification, tagging and hybridisa-
tion were performed according to the manufacturer’s
protocol. Array slides were scanned on the iScan Reader
(Illumina). Data analysis was performed using Genome
Studio version 2010.1 (Illumina). The HapMap control
set provided by the manufacturer was used as a control.
Results
Unique sequence positive sSMC
All unique sequence positive sSMC (Table 1) were cor-
rectly identified with MLPA with the centromere kits
(cases 1 and 20), telomere kits (cases 6 and 13) or both
(cases 3-5, 7, 11, 12, 14, 21-25) (see table 3) confirming
GTG/FISH results. There were no false negative cases.
a. Non-mosaic cases
The relative probe signals in most non-mosaic cases (see
table 1) correctly discriminated between 3 and 4 copies
of the investigated probes, with relative probe signals >
1.3 and < 1.5 for a trisomy and > 1.6 for a tetrasomy
(see table 3). In 3/23 non-mosaic cases a discrepancy
was found.
Case 1: Although amplification of EPHA3 confirmed the
results of FISH and DNA marker studies (sSMC=der(3)
(:p12.2->cen:) in case 1, the relative probe signals of the
3p11.2 marker EPHA3 in both centromere-kits were not
above 1.3 (1.178 in P181 and 1.226 in P182) as would be
expected in a full blown case. However, they were clearly
above the normal cut off value of 1.077 for both kits prob-
ably indicating loss of the sSMC in part of the cells and
therefore mosaicism at the time that DNA for MLPA was
isolated from the cell cultures.
Case 13 showed a full blown neo(15) in cultured AF
cells (8 cell clones investigated) (see Figure 1a), which is
an analphoid sSMC with a neocentromere and consist-
ing of two copies of the distal end of chromosome 15q.
However, the relative probe signals of the 15q-subtelo-
mere probes were only 1.45 and 1.428 in respectively
P036B and P070, indicative of a trisomy but not a tet-
rasomy as expected (Figure 1b).
In order to elucidate this discrepancy, genomic micro-
array analysis was performed. Investigations with the
HumanCytoSNP-12 indicate that this case is more com-
plex than initially thought which may explain the MLPA
results. Based on Log R ratio and B-allele frequency
(BAF), we expect mosaicism of different abnormal cell
lines containing different sSMC. However, BAF’s of 0, 1,
0.333 and 0.667 and absence of a BAF of 0.5 at 15q26.3
(in contrast to the region 15q24.1-q26.2) indicate a tris-
omy at 15qtel which confirms the MLPA results (see
Figure 1c).
In case 25 of an extra familial del(22)(q11.2) the
results of MLPA with the 22q11 probes in the four kits
were indicative for 4 copies of this chromosomal region:
relative probe signals were 1.770 and 1.621 (P181), 1.760
and 1.869 (P182), 1.688 (P036B) and 1.806 (P070)
(Figure 2b). This contradicts the FISH results with one
signal on the sSMC for two different 22cen-probes, one
for the rDNA-probe and one signal with the probe from
the Cat Eye Syndrome (CES)-region (Figure 2a).
HumanCytoSNP-12-analysis confirmed the sSMC to be
at least a partial duplication of chromosome 22, indi-
cated by a BAF of 0.5, resulting in 4 copies of the
sequences detected by the proximal 22q-probes in the 4
MLPA kits (Figure 2c).
b. Mosaic cases
In one out of four mosaic cases (case 3), MLPA cor-
rectly identified four copies of 9ptel (P070, P036B), 9p11
(p182) and 9p13.2 (P181) with relative probe signals >
1.6 (table 3). However, in three out of four mosaic cases
(cases 4, 6 and 20), the relative probe signals of some
probes were below the expected values (1.3 for a trisomy
and 1.6 for a tetrasomy). In these cases, the level of
mosaicism, which was determined in cultured AF cells,
was unknown in uncultured AF cells from which the
DNA for MLPA was isolated. Nevertheless, the sSMC in
all three cases could be identified by making use of our
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Table 2 Cut off values (median probe signal ±2 SD) for the different probes in the MLPA kits P181, P182, P036B and
P070
Probes P181 Cut off values (N = 95) Probes P182 Cut off values (N = 91)
Minimum Maximum Minimum Maximum
3p11.2 EPHA3 0,923 1,077 3p11.2 EPHA3 0,923 1,077
3q11.2 PROS1 0,907 1,093 3q11.2 PROS1 0,913 1,087
4p11 OCIAD1 0,880 1,114 4p11 OCIAD1 0,880 1,114
4q12 SGCB 0,946 1,054 4q12 USP46 0,919 1,081
9p13.2 IGFBPL1 0,902 1,098 9p11 EXOSC3 0,940 1,060
9q13 TJP2 0,933 1,067 9q13 TJP2 0,909 1,079
12p11.21 PKP2 0,888 1,112 12p11.21 PKP2 0,894 1,090
12q12 KIF21A 0,899 1,101 12q12 KIF21A 0,886 1,114
13q11 HSMPP8 0,881 1,119 13q11 HSMPP8 0,924 1,060
13q11 ZNF198 0,930 1,066 13q11 ZNF198 0,881 1,119
14q11.2 ADPRTL2 0,863 1,115 14q11.2 ADPRTL2 0,913 1,079
14q11.2 APEX 0,917 1,083 14q11.2 APEX 0,932 1,066
15q11.2 NIPA2 0,883 1,097 15q11.2 NIPA2 0,864 1,128
15q11.2 NDN 0,916 1,078 15q11.2 MKRN3 0,874 1,126
16p11.2 TGFB1I1 0,882 1,098 16p11.2 ERAF 0,927 1,071
16q12 ORC6L 0,914 1,086 16q12 VPS35 0,899 1,101
17p11.2 MAP2K3 0,934 1,064 17p11.2 MAP2K3 0,828 1,170
17q11.1 WSB1 0,927 1,073 17q11.1 WSB1 0,931 1,069
20p11.2 PYGB 0,894 1,102 20p11.21 ZNF337 0,914 1,086
20q11.21 DUSP15 0,912 1,088 20q11.21 REM1 0,893 1,075
21q11 STCH 0,911 1,089 21q11 STCH 0,896 1,104
21q11 SAMSN1 0,861 1,153 21q11 SAMSN1 0,889 1,111
22q11.2 CECR5 0,872 1,086 22q11.2 CECR1 0,877 1,083
22q11.2 CECR1 0,901 1,089 22q11.2 SLC25A18 0,916 1,084
Probes P036B Cut off values (N = 104) Probes P070 Cut off values (N = 105)
Minimum Maximum Minimum Maximum
3p CHL1 0.890 1.110 3p CHL1 0.916 1.080
3q BDH 0.905 1.092 3q KIAA0226 0.933 1.067
4p FLJ20265 0.900 1.101 4p ZNF141 0.828 1.172
4q FRG1 0.744 1.239 4q FRG1 0.865 1.143
9p DMRT1 0.897 1.103 9p FLJ00026 0.915 1.083
9q MRPL41 0.847 1.148 9q EU-HMTase1 0.935 1.065
12p SLC6A12 0.947 1.053 12p RBBP2 0.937 1.063
12q ZNF10 0.858 1.126 12q ZNF10 0.909 1.091
13p PSPC1 0.914 1.074 13p PSPC1 0.900 1.116
13q F7 0.883 1.116 13q CDC16 0.923 1.073
14p HEI10 0.919 1.081 14p ADPRTL2 0.929 1.071
14q MTA1 0.859 1.143 14q MTA1 0.906 1.094
15p CYFIP1 0.925 1.075 15p NDN 0.908 1.092
15q ALDH1A3 0.890 1.110 15q FLJ22604 0.938 1.062
16p POLR3K 0.894 1.108 16p DECR2 0.828 1.178
16q GAS11/GAS8 0.894 1.106 16q GAS11 0.936 1.060
17p RPH3AL 0.901 1.099 17p RPH3AL 0.843 1.163
17q TBCD 0.888 1.108 17q SECTM1 0.890 1.096
20p SOX12 0.843 1.157 20p FLJ22115 0.888 1.112
20q OPRL1 0.866 1.134 20q FLJ20517 0.883 1.117
21p RBM11 0.879 1.121 21p STCH 0.894 1.132
21q HMT1 0.853 1.147 21q S100B 0.921 1.065
22p BID 0.894 1.094 22p IL17R 0.837 1.163
22q RABL2B 0.875 1.127 22q ARSA 0.904 1.096
Only the chromosomes from which the sSMC in this paper are derived, are indicated.
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Table 3 MLPA results of 16 prenatal cases with a unique sequence positive sSMC
No sSMC DNA source
for MLPA
MLPA-results: copy number of sequence(s) in the kit, genes that they target and their abnormal
relative probe signal(s)
P181 P182 P036B P070
Copy
numb.
Relative probe
signal(s)
Copy
numb.
Relative probe
signal(s)
Copy
numb.
Relative probe
signal(s)
Copy
numb.
Relative probe
signal(s)
Mosaic
cases1
3 psu idic(9)
(q12)
(87,5%)
LTC-CV 4 IGFBPL1: 2.046 4 EXOSC3: 1.9013 4 DMRT1: 1.854 4 FLJ00026: 1.835
4 i(12)(p10)
(89%)
uAF 4 PKPR2: 1.5772 4 PKP2: 1.5202 4 SLC6A12: 1.718 4 RBBP2: 1.602
6 neo(12)
(pter->p12.3:)
(47%)
uAF 2 PKPR2: 1.006
KIF21A: 1.015
2 PKP2: 1.016
KIF21A: 1.045
4 SLC6A12: 1.765 4 RBBP2: 1.5192
20 r(20)
(q11.21q13.12)
(87%)
uAF 3 DUSP15: 1.461 3 REM1: 1.1833 2 SOX12:1.088
OPRL: 1.000
2 FLJ22115: 0.989
FLJ20517: 1.004
Non-mosaic
cases
1 der(3)
(:p12.2->cen:)
LTC-CV 3 EPHA3: 1.1783 3 EPHA3: 1.2263 2 CHL1: 0.974 2 CHL1: 0.965
5 i(12)(p10) uAF 4 PKPR2: 1.632 4 PKP2: 1.795 4 SLC6A12: 1.645 4 RBBP2: 1.699
7 der(13)t(4;13)
(q31.3;q13)
cAF 3 HSMPP8: 1.470
ZNF198: 1.322
3 HSMPP8:1.387
ZNF198: 1.534
3 PSPC1: 1.352
FRG1: 1.2354
3 PSPC1:1.495
FRG1: 1.300
11 der(14)t(14;16)
(q12;q21)
cAF 3 APEX: 1.358
ADPRTL2:1.310
3 ADPRTL2: 1.371
APEX: 1.410
3 HEI10: 1.393
GAS11/GAS8:
1.498
3 ADPRTL2: 1.462
GAS11: 1.381
12 inv dup(15)
(q12)
cAF 4 NDN: 1.702
NIPA2: 1.770
4 MKRN3: 1.635
NIPA2: 1.851
4 CYFIP1: 1.714 4 NDN: 1.668
13 neo(15)
(qtel->q2?4:)
cAF 2 NDN: 1.007
NIPA2: 0.932
2 MKRN3: 0.879
NIPA2: 1.087
3 ALDH1A3: 1.450 3 FLJ22604: 1.485
14 der(15)t(9;15)
(p12;q14)
uAF 3 NDN: 1.324
NIPA2: 1.406
IGFBPL1: 1.401
3 MKRN3: 1.493
NIPA2: 1.335
EXOSC3: 1.314
3 CYFIP1: 1.424
DMRT1: 1.455
3 NDN: 1.324
FLJ00026:
1.8205
21 inv dup(22)
(q11.21)
cAF 4 CECR1: 1.831
CECR5: 1.5726
4 CECR1: 1.830
SLC25A18: 1.773
4 BID: 1.825 36 IL17R: 1.548
22 inv dup(22)
(q11.21)
uAF 4 CECR1: 1.789
CECR5: 1.654
4 CECR1: 1.796
SLC25A18: 1.811
4 BID: 1.907 4 IL17R: 1.881
23 inv dup(22)
(q11.21)
uAF 4 CECR1: 1.694
CECR5: 1.724
4 CECR1: 1.711
SLC25A18: 1.691
4 BID: 1.940 4 IL17R: 2.080
24 inv dup(22)
(q11.21)
cAF 4 CECR1: 1.840
CECR5: 1.819
4 CECR1: 1.790
SLC25A18: 2.098
4 BID: 1.693 36 IL17R: 1.527
25 del(22)
(q11.2)
LTC-CV 4 CECR1: 1.770
CECR5: 1.621
4 CECR1: 1.760
SLC25A18: 1.869
4 BID: 1.688 4 IL17R: 1.806
LTC-CV = long-term cultured chorionic villi; uAF = uncultured amniotic fluid cells; cAF = cultured amniotic fluids cells.
1: Level of mosaicism was determined in cultured cells, whereas DNA from uncultured cells was used for MLPA in cases 4, 6 and 20.
2: Although relative probe signals indicate 3 copies (<1.6) we interpreted these results as 4 copies because of mosaicism in the cell cultures.
3 relative probe signal is clearly above the normal cut off value but < 1.3, probably indicating mosaicism.
4 the relative probe signal of 4qtel probe (FRG1) is in fact below the cut off value of 1.239. The FRG1 specific probes in the P036 kits were found not to be
reliable by the manufacturer due to the presence of population specific SNP’s in FRG1 (see website of MRC-Holland).
5 The probe for 9p in the P070 kit was found to be duplicated in some healthy individuals (see MRC Holland-website) which may explain the relative probe
signal of 1.820 indicating 4 instead of 3 copies of 9ptel.
6 The relative probe signal of the sequence targeting CECR5 in case 21 and IL17R in cases 21 and 24 is < 1.6 and therefore indicating 3 instead of 4 copies.
However, on the basis of the relative probe signals of the other probes in the same and/or other kits, we assume the presence of 4 copies of CECR5 and/or IL17R
on the sSMC in cases 21 and 24.
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own calculated cut off values (table 2) with relative
probe signals of the involving probes above the normal
cut off values in all kits.
Unique sequence negative sSMC
The unique sequence negative sSMC (cases 2, 8-10, 15-
19, 26-30) all showed normal MLPA results with relative
probe signals between the normal cut off values 0.7 and
1.3 confirming GTG/FISH results. There were no false
positive cases.
Discussion
sSMC, when detected with conventional cytogenetic
banding techniques, are still a problem as they often are
too small or without a specific banding pattern to be
considered for their chromosomal origin by traditional
$
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Figure 1 Identification of the sSMC in case 13 with GTG and FISH (a), MLPA (b) and SNP array analysis (c). a. GTG and FISH results: left:
partial karyotype of 2 cells showing a normal chromosome 15 on the left and the sSMC on the right. Middle: partial metaphase after FISH with
WCP15. Three chromosomes, both normal chromosomes 15 and the sSMC (arrow), are stained, proving the chromosome 15 origin of the sSMC.
Right: Partial metaphase after FISH with probe p80, located at 15q25-qter [37], showing 2 signals on both ends of the sSMC (arrow) indicative for
a neo(15). b. MLPA results with the kits P036B (left) and P070 (right). The probes targeting ALDH1A3 and FLJ22604 (within red circle), respectively,
both located at 15qtel, are clearly elevated but below 1.6 indicating 3 copies of both genes instead of four on the sSMC. c. HumanCytoSNP-12
result. Only chromosome 15 is depicted. The upper part shows the B-allele frequency (BAF) and the lower part shows the Log2 intensity along
chromosome 15. Based on BAF (absence of a BAF of 0.5 at 15q26.3 while a meiotic origin is likely due to the presence of a BAF of 0.5 in a large
part of the sSMC, indicating the presence of a third haplotype) and Log2 ratio (indicating 3 copies of the most distal end of 15q), the MLPA
result of a trisomy at the distal q-arm at 15q26.3, is confirmed.
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banding techniques. Therefore, molecular cytogenetic
techniques are often needed for further characterisation.
Since the phenotypic consequences of a sSMC will
greatly depend on its genetic content and chromosomal
origin, it is of particular clinical importance to rapidly
distinguish unique sequence-negative from unique
sequence-positive sSMC because the former are less
likely to be associated with an abnormal fetal outcome.
For a collection of all available reported sSMC cases, see
the sSMC database [22].
Different papers describe the use of genomic array
analysis for identification of sSMC [15,16,23,24]. The big
advantage of this technique is that the exact chromoso-
mal content of the unique-sequence positive sSMC can
be determined in one reaction, although targeted FISH
is often used following an abnormal array result and is
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Figure 2 Identification of the familial sSMC in case 25: GTG and FISH (a), MLPA (b) and HumanCytoSNP-12 (c) results. a. Left. GTG
partial metaphase showing the sSMC (arrow). 2nd picture
: partial metaphase after FISH with the ribosomal DNA probe r521, showing one signal
on the sSMC (arrow) and on the short arm of all acrocentric chromosomes. 3rd picture
: partial metaphase after FISH with p190.22 (22cen) (green)
and 22qtel probe (red) showing only one centromere signal and no 22qtel signal on the sSMC (arrow). Both normal chromosomes 22 are
positive with 22cen as well as with 22qtel probe. Right: partial metaphase after FISH with a Cat Eye Syndrome critical region probe 102D10
showing one signal on the sSMC (arrow) and on both normal chromosomes 22. b. MLPA results with centromere kit P182 (left) en telomere kit
P070 (right). The relative probe signals of the sequences targeting CECR1 and SLC25A18 in P182 and IL17R in P070 (in red circle) are clearly > 1.6
indicating 4 copies of these sequences on the sSMC. c. HumanCytoSNP-12 result. Only chromosome 22 is depicted. The upper part shows the B-
allele frequency (BAF) and the lower part shows the Log R Ratio along chromosome 22. Based on the BAF (presence of a BAF of 0.5 in at least a
part of the maternally inhereted sSMC, indicating the presence of a meiotic tetrasomy), the MLPA result of a partial tetrasomy 22q11, is
confirmed.
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sometimes necessary to determine the structure of the
sSMC [24]. However, genomic array analysis is labour
intensive, time-consuming and expensive. The use of
the MLPA technique for characterisation of some speci-
fic sSMC has already been described in postnatal cyto-
genetics [25-28]. In this paper, we show that MLPA
with centromere and telomere kits may be a quick initial
approach for sSMC characterisation in prenatal diagno-
sis when time is limited. From every AF sample that we
receive in our laboratory 4 ml is used for direct DNA
isolation. As soon as a sSMC is found, this DNA can be
used for MLPA and results are available within less than
24 hours. In case of a positive result, targeted FISH and/
or array on (un)cultured AF cells may be used for con-
firmation and further identification. However, as with
array analysis, MLPA will give normal results in case of
an unique sequence-negative sSMC or in case of low
level mosaicism [16]. Therefore, other techniques such
as cenM-FISH [8] or sequential targeted FISH [29],
although labour-intensive and frequently time-consum-
ing, will be necessary for determining the chromosomal
origin. Since such a sSMC most probably does not con-
tain euchromatin, in the meanwhile, the parents can be
karyotyped after reassurance.
Despite the development of molecular techniques for
sSMC identification, conventional staining techniques
are still valuable. Since 35% of the marker chromosomes
with a known chromosomal origin are derived from
chromosome 15 [30], the first thing to do in case of a
satellited sSMC is a DA-DAPI staining. If positive, tar-
geted FISH with chromosome 15 specific probes can be
applied for further identification. If negative, FISH with
a 13/21 and 14/22 centromere probe in conjunction
with subcentromere probes for these 4 chromosomes
can quickly elucidate the chromosomal content of the
sSMC. In case of a non-satellited sSMC, MLPA might
be a rapid and rather non-expensive technique for dis-
tinguishing between an unique sequence-positive and
-negative sSMC.
The centromere kits P181 and P182 are presented by
MRC Holland as kits for identification of sSMC. How-
ever, we recommend using the telomere kits in addition
to these centromere kits for sSMC identification for
three reasons. Firstly, by using only the centromere kits,
the neo(12) and neo(15) would both have been missed.
This type of sSMC, first described by Blennow [31] is
rare. Up till now about ~90 neocentric acentric marker
chromosomes have been described in patients with idio-
pathic mental retardation but also in cancer cells
[32,33]. Secondly, the sSMC in cases 7 and 11 could be
correctly identified as being unbalanced translocations
by using centromere concomitant with telomere kits.
Although rare, this type of sSMC, the so-called unique
complex sSMC which are derived from more than one
chromosome, may be underdiagnosed as suggested by
Trifonov et al. [34], and MLPA with centromere and tel-
omere kits may enhance their detection rate. And
finally, since most sSMC are derived from the acro-
centric chromosomes, the simultaneous use of centro-
mere and telomere kits allows for more markers to be
tested in the subcentromeric region since the telomere
kits also contain probes in the proximal long arm of the
acrocentric chromosomes instead of a specific short arm
subtelomere probe which they lack.
In 5/6 mosaic cases with the level of mosaicism deter-
mined in cultured cells, DNA isolated from uncultured
AF cells was used for MLPA hampering the interpreta-
tion of the results. For instance, normal MLPA results
in cases 18 and 19 are most probably explained by
absence of unique sequences on both sSMC. However,
due to low-level mosaicism at least in the AF cell cul-
tures and therefore probably also in the uncultured AF
cells used for MLPA, a normal result caused by low-
level mosaicism can never be excluded. It is known that
discrepancies may exist concerning mosaicism level
between cultured and uncultured AF cells with the level
often being higher in uncultured cells since these are
not subjected to selection, mostly in favour of normal
cells as seen in cell cultures. However, the reverse has
also been observed in some cases of tissue specific
mosaicism if the contribution of the affected organ or
organsystem to the total AF cell population is small
[35], but also in cases of generalised mosaicism [36].
From this experience, we learned that it is important to
make FISH-slides at the time of DNA isolation neces-
sary for determination of the level of mosaicism in the
DNA sample enabling a proper interpretation of
molecular results.
In cases 13 and 25 we show that the use of molecular
techniques such as MLPA and array analysis may show
that some sSMC are much more complex than initially
thought on the basis of conventional banding techniques
and FISH. At the moment we are performing further
FISH studies in order to elucidate the exact structure of
the sSMC in both cases. Tsuchya et al. [24] already
published the uncoverage of unexpected complexity in
the form of complex rearrangements of some sSMC
when they used array CGH. This will ultimately lead
to a more accurate sSMC-phenotype correlation which
is important for proper counselling of the prospective
parents when the sSMC is found prenatally.
Conclusion
In this paper we show that MLPA with centromere (P181
and P182)-and telomere (P036B and P070)-kits allow for
the rapid differentiation between unique sequence posi-
tive and negative sSMC. As compared to multicolour
FISH techniques and microarray analysis, MLPA is a
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rather non-expensive and easy to perform technique in
most clinical cytogenetic laboratories for the rapid eluci-
dation of the harmfulness of a prenatally detected sSMC
with results available within 24 hours.
Additional material
Additional file 1: Supplemental Table. 29 prenatal cases with a sSMC:
indication, sSMC identification with conventional staining and FISH
techniques, positive or negative for euchromatin and final karyotype.
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